Search results
Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in...
The Conversation· 1 day agoAlmost 3 million people worldwide have multiple sclerosis (MS) – an autoimmune disease caused by the immune system mistakenly attacking the brain and central nervous system. While treatments ...
Mark Cavendish knighted in King's Birthday Honours ahead of final Tour de France
Cyclingnews· 5 days agoCycling’s best-ever sprinter Mark Cavendish has been knighted and will take aim at a record 35th...
Multiple sclerosis: Can dietary choices influence risk?
Medical News Today· 6 days agoExperts have yet to understand why multiple sclerosis (MS) develops, but current research suggests...
How Alice in Wonderland Syndrome Distorts Your Perception
Verywell Mind via Yahoo News· 15 hours agoAlice in Wonderland Syndrome (AIWS) is a brain disorder that causes visual distortions. Learn about...
Case Study: Sudden Blurred Vision in a Young Woman
MedPage Today· 6 days ago"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. "Medical Journeys" chart a ...
Atara Biotherapeutics Stock to Reverse Split on Thursday, June 20th (NASDAQ:ATRA)
ETF DAILY NEWS· 1 day agoAtara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report)’s stock is going to reverse split on the morning of Thursday, June 20th. The 1-25 reverse split was announced on Thursday, June 20th.
Post-viral arthritis: Causes, symptoms, and treatments
Medical News Today· 5 days agoViral arthritis is an uncommon form of arthritis that occurs following a viral infection. It can...
Advice | What the latest science says about Lyme disease
Washington Post· 2 days agoLyme disease is a bacterial infection that spreads through tick bites. It may cause flu-like symptoms and a bull’s-eye-shaped rash. Most people fully recover after a few weeks of antibiotic ...
Oppenheimer Increases Moderna (NASDAQ:MRNA) Price Target to $179.00
ETF DAILY NEWS· 5 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price hoisted by analysts at Oppenheimer from $163.00 to $179.00 in a research report issued to clients and investors on Wednesday, Benzinga ...